Literature DB >> 10928113

Hyperthermia enhanced chemosensitivity of human malignant glioma cells.

M Hermisson1, M Weller.   

Abstract

In an effort to overcome chemoresistance of human malignant glioma cells, the modulation of drug-induced cell death by hyperthermia was assessed in 4 human malignant glioma cells lines, LN-18, LN-229, T98G and U87MG. Compared to normothermic conditions, pulsed 24 h drug exposure enhanced the sensitivity of glioma cells most strikingly with teniposide, treosulfan, topotecan and cisplatin, moderately with vincristine, CCNU and doxorubicin, but not with gemcitabine. Susceptibility to hyperthermia-mediated drug sensitization, varied significantly with T98G and LN-229 being strongly sensitized and U87MG being most resistant to the effects of hyperthermia. Hyperthermia did not significantly modulate drug-induced changes in cell cycle distribution. The degree of sensitization was independent of p53 status and of multidrug resistance (mdr) activity. Hyperthermia may thus be a useful approach to overcome, chemoresistance of human malignant glioma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928113

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Successful treatment of solitary bone metastasis of non-small cell lung cancer with bevacizumab and hyperthermia.

Authors:  Gábor Rubovszky; Tünde Nagy; Mária Gődény; András Szász; István Láng
Journal:  Pathol Oncol Res       Date:  2012-07-03       Impact factor: 3.201

Review 2.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 3.  Current status of oncothermia therapy for lung cancer.

Authors:  Andras Szasz
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-04-10

Review 4.  Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.

Authors:  Arlene L Oei; Lianne E M Vriend; Johannes Crezee; Nicolaas A P Franken; Przemek M Krawczyk
Journal:  Radiat Oncol       Date:  2015-08-07       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.